Clinical Trial Update: A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine [Phase 1]

View source ↗

Summary

Phase 1 trial update for a seasonal trivalent split, inactivated influenza vaccine; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Influenza

Drugs mentioned

• Seasonal Trivalent Split, Inactivated Influenza Vaccine

Snippet

Sponsor: Institute of Virology, Vaccines and Sera, Torlak | Conditions: Influenza, Human | Phase 1 | Status: COMPLETED | Results posted: 2019-01-15